147 related articles for article (PubMed ID: 32017943)
1. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
[TBL] [Abstract][Full Text] [Related]
2. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.
Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388
[TBL] [Abstract][Full Text] [Related]
4. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
5. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
[TBL] [Abstract][Full Text] [Related]
6. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
7. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
8. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy.
Choubey M; Bora P
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371562
[TBL] [Abstract][Full Text] [Related]
12. Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.
Sekiyama E; Saint-Geniez M; Yoneda K; Hisatomi T; Nakao S; Walshe TE; Maruyama K; Hafezi-Moghadam A; Miller JW; Kinoshita S; D'Amore PA
FASEB J; 2012 Feb; 26(2):567-75. PubMed ID: 22067481
[TBL] [Abstract][Full Text] [Related]
13. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
[TBL] [Abstract][Full Text] [Related]
14. Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.
De Rossi G; Vähätupa M; Cristante E; Arokiasamy S; Liyanage SE; May U; Pellinen L; Uusitalo-Järvinen H; Bainbridge JW; Järvinen TAH; Whiteford JR
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1374-1389. PubMed ID: 33596666
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
18. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
[TBL] [Abstract][Full Text] [Related]
19. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
20. Metrnl inhibits choroidal neovascularization by attenuating the choroidal inflammation via inactivating the UCHL-1/NF-κB signaling pathway.
Zhang L; Li Y; Wu Z; Shen Q; Zeng C; Liu H; Zhang X; Yang J; Liu Q; Tang D; Ou K; Fang Y
Front Immunol; 2024; 15():1379586. PubMed ID: 38745648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
